233 related articles for article (PubMed ID: 31535357)
1. Clinical and genetic analysis of idiopathic normophosphatemic tumoral calcinosis in 19 patients.
Zuo QY; Cao X; Liu BY; Yan D; Xin Z; Niu XH; Li C; Deng W; Dong ZY; Yang JK
J Endocrinol Invest; 2020 Feb; 43(2):173-183. PubMed ID: 31535357
[TBL] [Abstract][Full Text] [Related]
2. Calcareous lesions of the distal extremities resembling tumoral calcinosis (tumoral calcinosislike lesions): clinicopathologic study of 43 cases emphasizing a pathogenesis-based approach to classification.
Laskin WB; Miettinen M; Fetsch JF
Am J Surg Pathol; 2007 Jan; 31(1):15-25. PubMed ID: 17197915
[TBL] [Abstract][Full Text] [Related]
3. A novel
Zuo Q; Yang W; Liu B; Yan D; Wang Z; Wang H; Deng W; Cao X; Yang J
Front Endocrinol (Lausanne); 2022; 13():1008800. PubMed ID: 36213261
[TBL] [Abstract][Full Text] [Related]
4. Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein.
Chefetz I; Ben Amitai D; Browning S; Skorecki K; Adir N; Thomas MG; Kogleck L; Topaz O; Indelman M; Uitto J; Richard G; Bradman N; Sprecher E
J Invest Dermatol; 2008 Jun; 128(6):1423-9. PubMed ID: 18094730
[TBL] [Abstract][Full Text] [Related]
5. Tumoral calcinosis of the hand: three unusual cases with painful swelling of small joints.
Kim HS; Suh JS; Kim YH; Park SH
Arch Pathol Lab Med; 2006 Apr; 130(4):548-51. PubMed ID: 16594750
[TBL] [Abstract][Full Text] [Related]
6. Successful treatment approaches for tumoral calcinosis in children and young people: A condition of diverse pathogenesis.
Anilkumar A; Högler W; Bursell J; Nadar R; Ryan F; Randell T; Shaw NJ; Uday S
Bone; 2024 May; 182():117049. PubMed ID: 38364881
[TBL] [Abstract][Full Text] [Related]
7. Proposal for a pathogenesis-based classification of tumoral calcinosis.
Smack D; Norton SA; Fitzpatrick JE
Int J Dermatol; 1996 Apr; 35(4):265-71. PubMed ID: 8786184
[TBL] [Abstract][Full Text] [Related]
8. A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis.
Topaz O; Indelman M; Chefetz I; Geiger D; Metzker A; Altschuler Y; Choder M; Bercovich D; Uitto J; Bergman R; Richard G; Sprecher E
Am J Hum Genet; 2006 Oct; 79(4):759-64. PubMed ID: 16960814
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis.
Hershkovitz D; Gross Y; Nahum S; Yehezkel S; Sarig O; Uitto J; Sprecher E
J Invest Dermatol; 2011 Mar; 131(3):662-9. PubMed ID: 21160498
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic Tumoral Calcinosis with Unusual Presentation-Case Report with Review of Literature.
Banshelkikar SN; Argekar H; Bhoir A
J Orthop Case Rep; 2014; 4(3):59-62. PubMed ID: 27298986
[TBL] [Abstract][Full Text] [Related]
11. Tumoral calcinosis: radiologic-pathologic correlation.
Steinbach LS; Johnston JO; Tepper EF; Honda GD; Martel W
Skeletal Radiol; 1995 Nov; 24(8):573-8. PubMed ID: 8614855
[TBL] [Abstract][Full Text] [Related]
12. [Tumoral calcinosis with superinfection and sepsis].
Oeggerli P; Maurer R; Kistler H
Schweiz Med Wochenschr; 1991 Sep; 121(38):1387-92. PubMed ID: 1925469
[TBL] [Abstract][Full Text] [Related]
13. Treatment and outcomes of tumor-induced osteomalacia associated with phosphaturic mesenchymal tumors: retrospective review of 12 patients.
Zuo QY; Wang H; Li W; Niu XH; Huang YH; Chen J; You YH; Liu BY; Cui AM; Deng W
BMC Musculoskelet Disord; 2017 Sep; 18(1):403. PubMed ID: 28934935
[TBL] [Abstract][Full Text] [Related]
14. A novel recessive mutation of fibroblast growth factor-23 in tumoral calcinosis.
Masi L; Gozzini A; Franchi A; Campanacci D; Amedei A; Falchetti A; Franceschelli F; Marcucci G; Tanini A; Capanna R; Brandi ML
J Bone Joint Surg Am; 2009 May; 91(5):1190-8. PubMed ID: 19411468
[TBL] [Abstract][Full Text] [Related]
15. Tumoral calcinosis with hyperphosphatemia.
Mahadevan S; Adhisivam B; Kumar CN
Indian J Pediatr; 2005 Oct; 72(10):889-90. PubMed ID: 16272668
[TBL] [Abstract][Full Text] [Related]
16. Normophosphatemic type tumoral calcinosis associated with chronic recurrent multifocal osteomyelitis: a case report.
Yüksel HY; Yılmaz S; Gürbüzel M
Acta Orthop Traumatol Turc; 2011; 45(2):124-9. PubMed ID: 21610312
[TBL] [Abstract][Full Text] [Related]
17. Mouse Samd9l is not a functional paralogue of the human SAMD9, the gene mutated in normophosphataemic familial tumoral calcinosis.
Li Q; Guo H; Matsui H; Honda H; Inaba T; Sundberg JP; Sprecher E; Uitto J
Exp Dermatol; 2012 Jul; 21(7):554-6. PubMed ID: 22716256
[TBL] [Abstract][Full Text] [Related]
18. Tumoral calcinosis. Case report with treatment failure.
Walentynowicz JE; Mahoney MD; Saldana MJ
Orthop Rev; 1989 Jun; 18(6):687-90. PubMed ID: 2664669
[TBL] [Abstract][Full Text] [Related]
19. [SAMD9 mutation in normophosphatemic familial tumoral calcinosis].
Dereure O
Ann Dermatol Venereol; 2007 May; 134(5 Pt 1):505. PubMed ID: 17507861
[No Abstract] [Full Text] [Related]
20. Primary hyperphosphatemic tumoral calcinosis: a case report.
Huang J; Cao LG; Zhang TR; Li SM; Meng QQ
Osteoporos Int; 2022 Jan; 33(1):309-312. PubMed ID: 34245344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
